You can buy or sell Helius Medical and other stocks, options, ETFs, and crypto commission-free!
Helius Medical Technologies, Inc. operates as a medical technology company, which engages in the development of products for the treatment of neurological symptoms caused by disease and trauma. It focuses on licensing and acquiring platform technologies that amplify the brain's ability to heal itself. Read More The company was founded in 2014 and is headquartered in Newtown, PA.
52 Week High
52 Week Low
Yahoo FinanceMay 9
Helius Medical Technologies, Inc. Reports First Quarter 2019 Financial Results and Provides Business Update; Reaffirms Full Year 2019 Outlook
NEWTOWN, Pa., May 09, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (HSDT) (HSM.TO) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today reported financial results for the first quarter ended March 31, 2019. First Quarter 2019 Financial Summary Revenue of $0.7 million, compared to no revenue in first quarter 2018. Operating loss of $6.8 million, compared to operating loss of $4.7 million in first quarter 2018. Net income of $1.3 million, compared to net...
Expected Aug 8, Pre-Market